Furthermore, using animal models of experimental NEC, probiotics have been shown to inhibit inflammation, reduce apoptosis, inhibit Toll-like receptor 4 (TLR4) activation, and protect against intestinal mucosal barrier breakdown [28,29,30,31,32]. Here, TLR4 is linked to necrotizing enterocolitis.